Award
NIH Reporter #11292398
Targeting the Opposing Roles of Prostaglandin E2 Receptors, EP3 and EP4, in the Pathogenesis of Type One Diabetes
Recipient
Vanderbilt University
Award Amount
$34,814.00
Ceiling
$34,814.00
Awarded
February 13, 2026
Identifier
11292398
NIH grant awarded to Vanderbilt University for research on prostaglandin E2 receptors in type 1 diabetes, aiming to reduce β-cell death and promote regeneration.
Description
This NIH grant opportunity funds research on type 1 diabetes focusing on prostaglandin E2 receptors. The project aims to investigate pathways that could mitigate β-cell death and promote regeneration. Funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).